Molekule Air Mini Based On NRI’s PECO Technology Launched At INR 37,999 In India That Destroys Airborne Pollutants

- Award-Winning PECO Air Purification Technology, developed by NRI & Distinguished Professor Dr. D. Yogi Goswami

- Available via Amazon.in at INR 37,999

Molekule, a leader in reinventing air purification, today announced the launch of Air Mini purifier in India through authorised resellers on Amazon.in. With this, Molekule introduces its award-winning patented Photo Electrochemical Oxidation (PECO) air purification technology to Indian consumers.

Molekule as a brand has seen a rapid surge in interest for its products globally. Molekule’s initial offering to the Indian market, the award-winning Air Mini is currently available on Amazon.in at a retail price of INR 37,999. Air Mini is designed for rooms up to up to 23 sq meters – ideal for apartments, bedrooms, and home offices. The purifier has 5 different fan speeds that can be adjusted as required. The energy consumption is between 18-53 watts, and the noise level varies between 36-62dBA, pending fan speed. It also uses a hybrid of Molekule’s Pre-Filter and PECO-Filter in a single filter.

The proprietary PECO Technology is developed by the award-winning Dr. D. Yogi Goswami, a Non-Resident Indian (NRI). PECO technology is capable of destroying a wide range of airborne pollutants compared to traditional air purifiers. The broad range of pollutants addressed by PECO includes the destruction of bacteria, viruses, mold, chemicals, and particulate matter in the air, among many other contaminants. Molekule air purifiers have PECO-Filers coated in a proprietary catalyst, which, when activated by UV-A light, releases hydroxyl radicals that break the molecular bonds of viruses, bacteria, mold, allergen, odors, pollen, dander, and more.*

 

Molekule’s PECO technology is whisper-quiet, ozone-free, and has a robust proven history of using oxidation to destroy airborne pollutants. Various independent air quality testing laboratories and internal testing has validated the effectiveness of Molekule’s proprietary PECO technology, backed by testing papers.*

*Virus testing conducted on MS2 Bacteriophage.

 

New Delhi –  10 February, 2021